Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 766

1.

Who can we save after an intraprocedural catastrophe during TAVR?

Satler L, Thourani VH.

Catheter Cardiovasc Interv. 2018 Jul;92(1):157-158. doi: 10.1002/ccd.27693.

PMID:
30917222
2.

Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients.

Sorajja P, Moat N, Badhwar V, Walters D, Paone G, Bethea B, Bae R, Dahle G, Mumtaz M, Grayburn P, Kapadia S, Babaliaros V, Guerrero M, Satler L, Thourani V, Bedogni F, Rizik D, Denti P, Dumonteil N, Modine T, Sinhal A, Chuang ML, Popma JJ, Blanke P, Leipsic J, Muller D.

J Am Coll Cardiol. 2019 Mar 26;73(11):1250-1260. doi: 10.1016/j.jacc.2018.12.066.

PMID:
30898200
3.

Transcatheter Aortic Valve Replacement in Low-Risk Patients: One-Year Results from the LRT Trial.

Waksman R, Corso PJ, Torguson R, Gordon P, Ehsan A, Wilson SR, Goncalves J, Levitt R, Hahn C, Parikh P, Bilfinger T, Butzel D, Buchanan S, Hanna N, Garrett R, Buchbinder M, Asch F, Weissman G, Ben-Dor I, Shults C, Bastian R, Craig PE, Ali S, Garcia-Garcia HM, Kolm P, Zou Q, Satler LF, Rogers T.

JACC Cardiovasc Interv. 2019 Mar 8. pii: S1936-8798(19)30656-9. doi: 10.1016/j.jcin.2019.03.002. [Epub ahead of print]

PMID:
30860059
4.

Relation of Sex and Race to Outcomes in Patients Undergoing Percutaneous Intervention With Drug-Eluting Stents.

Iantorno M, Torguson R, Kolm P, Gajanana D, Suddath WO, Rogers T, Bernardo NL, Ben-Dor I, Gai J, Satler LF, Garcia-Garcia HM, Weintraub WS, Waksman R.

Am J Cardiol. 2019 Mar 15;123(6):913-918. doi: 10.1016/j.amjcard.2018.12.021. Epub 2018 Dec 19.

PMID:
30595392
5.

Emergent valve-in-valve transcatheter aortic valve replacement in patient with acute aortic regurgitation and cardiogenic shock with preoperative extracorporeal membrane oxygenator: A case report and review of the literature.

Iantorno M, Ben-Dor I, Rogers T, Gajanana D, Attaran S, Buchanan KD, Satler LF, Shults CC, Thourani VH, Waksman R.

Cardiovasc Revasc Med. 2018 Dec;19(8S):68-70. doi: 10.1016/j.carrev.2018.11.007. Epub 2018 Nov 12.

PMID:
30455139
6.

A new simple tool to manage the no reflow phenomenon.

Satler L.

Catheter Cardiovasc Interv. 2018 Nov 1;92(5):895-896. doi: 10.1002/ccd.27926.

PMID:
30450710
7.

A word of caution using self-expanding transcatheter aortic valve-frame infolding.

Ben-Dor I, Rogers T, Satler LF, Waksman R.

Catheter Cardiovasc Interv. 2019 Feb 15;93(3):555-558. doi: 10.1002/ccd.27870. Epub 2018 Oct 30.

PMID:
30378244
8.

Surgical Aortic Valve Replacement in the Transcatheter Aortic Valve Replacement Era: Implications for the Heart Team.

Thourani VH, Edelman JJ, Satler LF, Weintraub WS.

JACC Cardiovasc Interv. 2018 Nov 12;11(21):2157-2159. doi: 10.1016/j.jcin.2018.07.057. Epub 2018 Oct 17. No abstract available.

PMID:
30343021
9.

Transcatheter Mitral-Valve Repair in Patients with Heart Failure.

Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ; COAPT Investigators.

N Engl J Med. 2018 Dec 13;379(24):2307-2318. doi: 10.1056/NEJMoa1806640. Epub 2018 Sep 23.

PMID:
30280640
10.

Comparison of coronary revascularization appropriateness for non-acute coronary syndrome cases under the 2017 update vs the 2012 appropriate use criteria.

Case BC, Geiser KM, Torguson R, Pichard AD, Satler LF, Waksman R, Ben-Dor I.

Catheter Cardiovasc Interv. 2019 Mar 1;93(4):620-625. doi: 10.1002/ccd.27895. Epub 2018 Oct 2.

PMID:
30280475
11.

Role of contractile reserve as a predictor of mortality in low-flow, low-gradient severe aortic stenosis following transcatheter aortic valve replacement.

Buchanan KD, Rogers T, Steinvil A, Koifman E, Xu L, Torguson R, Okubagzi PG, Shults C, Pichard AD, Ben-Dor I, Satler LF, Waksman R, Asch FM.

Catheter Cardiovasc Interv. 2019 Mar 1;93(4):707-712. doi: 10.1002/ccd.27914. Epub 2018 Oct 2.

PMID:
30280469
12.

Invited Commentary.

Attaran S, Rogers T, Satler L, Thourani VH.

Ann Thorac Surg. 2018 Dec;106(6):1725-1726. doi: 10.1016/j.athoracsur.2018.07.049. Epub 2018 Sep 21. No abstract available.

PMID:
30248318
13.

The impact of in-hospital P2Y12 inhibitor switch in patients with acute coronary syndrome.

Gajanana D, Weintraub WS, Kolm P, Rogers T, Iantorno M, Buchanan KD, Ben-Dor I, Pichard AD, Satler LF, Thourani VH, Torguson R, Okubagzi PG, Waksman R.

Cardiovasc Revasc Med. 2018 Dec;19(8):912-916. doi: 10.1016/j.carrev.2018.09.007. Epub 2018 Sep 11.

PMID:
30243963
14.

Coronary perfusion pressure and left ventricular hemodynamics as predictors of cardiovascular collapse following percutaneous coronary intervention.

Buchanan KD, Kolm P, Iantorno M, Gajanana D, Rogers T, Gai J, Torguson R, Ben-Dor I, Suddath WO, Satler LF, Waksman R.

Cardiovasc Revasc Med. 2019 Jan;20(1):11-15. doi: 10.1016/j.carrev.2018.09.005. Epub 2018 Sep 10.

PMID:
30217626
15.

Clinical Characteristics, Procedural Factors, and Outcomes of Percutaneous Coronary Intervention in Patients With Mechanical and Bioprosthetic Heart Valves.

Gajanana D, Rogers T, Weintraub WS, Iantorno M, Buchanan KD, Ben-Dor I, Pichard AD, Satler LF, Thourani VH, Torguson R, Okubagzi PG, Waksman R.

Am J Cardiol. 2018 Nov 1;122(9):1536-1540. doi: 10.1016/j.amjcard.2018.07.026. Epub 2018 Aug 3.

PMID:
30180957
16.

Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis.

Waksman R, Rogers T, Torguson R, Gordon P, Ehsan A, Wilson SR, Goncalves J, Levitt R, Hahn C, Parikh P, Bilfinger T, Butzel D, Buchanan S, Hanna N, Garrett R, Asch F, Weissman G, Ben-Dor I, Shults C, Bastian R, Craig PE, Garcia-Garcia HM, Kolm P, Zou Q, Satler LF, Corso PJ.

J Am Coll Cardiol. 2018 Oct 30;72(18):2095-2105. doi: 10.1016/j.jacc.2018.08.1033. Epub 2018 Aug 28.

PMID:
30170075
17.

Accuracy of predicted orthogonal projection angles for valve deployment during transcatheter aortic valve replacement.

Steinvil A, Weissman G, Ertel AW, Weigold G, Rogers T, Koifman E, Buchanan KD, Shults C, Torguson R, Okubagzi PG, Satler LF, Ben-Dor I, Waksman R.

J Cardiovasc Comput Tomogr. 2018 Sep - Oct;12(5):398-403. doi: 10.1016/j.jcct.2018.05.017. Epub 2018 May 26.

PMID:
30064937
18.

Predicted magnitude of alternate access in the contemporary transcatheter aortic valve replacement era.

Rogers T, Gai J, Torguson R, Okubagzi PG, Shults C, Ben-Dor I, Satler LF, Waksman R.

Catheter Cardiovasc Interv. 2018 Nov 1;92(5):964-971. doi: 10.1002/ccd.27668. Epub 2018 Jul 18.

PMID:
30019839
19.

Utility of an additive frailty tests index score for mortality risk assessment following transcatheter aortic valve replacement.

Steinvil A, Buchanan KD, Kiramijyan S, Bond E, Rogers T, Koifman E, Shults C, Xu L, Torguson R, Okubagzi PG, Pichard AD, Satler LF, Ben-Dor I, Waksman R.

Am Heart J. 2018 Jun;200:11-16. doi: 10.1016/j.ahj.2018.01.007. Epub 2018 Jan 31.

PMID:
29898837
20.

Successful transcatheter aortic valve replacement in an oversized 800 mm2 annulus and bicuspid aortic valve.

Buchanan KD, Rogers T, Shults C, Ben-Dor I, Satler LF, Waksman R.

Cardiovasc Revasc Med. 2018 Dec;19(8S):65-67. doi: 10.1016/j.carrev.2018.03.023. Epub 2018 Mar 29.

PMID:
29716809

Supplemental Content

Loading ...
Support Center